3.61
price down icon6.96%   -0.27
after-market Dopo l'orario di chiusura: 3.61
loading
Precedente Chiudi:
$3.88
Aprire:
$3.8
Volume 24 ore:
2,332
Relative Volume:
0.10
Capitalizzazione di mercato:
$66.03M
Reddito:
-
Utile/perdita netta:
$-12.63M
Rapporto P/E:
-5.2002
EPS:
-0.6942
Flusso di cassa netto:
$-12.18M
1 W Prestazione:
-9.07%
1M Prestazione:
-6.48%
6M Prestazione:
-17.95%
1 anno Prestazione:
+9.07%
Intervallo 1D:
Value
$3.61
$3.90
Intervallo di 1 settimana:
Value
$3.61
$4.15
Portata 52W:
Value
$2.20
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
Nome
Genenta Science Spa Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
GNTA's Discussions on Twitter

Confronta GNTA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GNTA
Genenta Science Spa Adr
3.61 66.03M 0 -12.63M -12.18M -0.6942
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-06-29 Ripresa ROTH MKM Buy
2022-07-25 Iniziato H.C. Wainwright Buy
2022-01-13 Iniziato Maxim Group Buy

Genenta Science Spa Adr Borsa (GNTA) Ultime notizie

pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Mar 19, 2025
pulisher
Jan 10, 2025

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Jan 10, 2025
pulisher
Jan 09, 2025

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewswire Inc.

Jan 09, 2025
pulisher
Dec 30, 2024

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Dec 30, 2024
pulisher
Dec 20, 2024

Genenta Science Updates ATM Sales Agreement with New Agent - TipRanks

Dec 20, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading resumes - TipRanks

Nov 29, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading halted, volatility trading pause - TipRanks

Nov 29, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance

Nov 13, 2024
pulisher
Oct 23, 2024

Genenta Science CEO to present at U.S. Senate meeting - TipRanks

Oct 23, 2024
pulisher
Oct 03, 2024

Genenta Science receives Buy rating amid trial approval - Investing.com

Oct 03, 2024
pulisher
Apr 02, 2024

Genenta Science Announces Shareholder Meeting - TipRanks

Apr 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Mar 04, 2024

DHR Stock Quote Price and Forecast - CNN

Mar 04, 2024
pulisher
Jun 05, 2015

Danaher (DHR) Stock Price, News & Analysis - MarketBeat

Jun 05, 2015

Genenta Science Spa Adr Azioni (GNTA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):